Amanda Yu

Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies

Reducing HPV-Associated Cancer Globally

The Second Canadian Symposium on Hepatitis C Virus: A Call to Action

Hepatocellular carcinoma

Thymoquinone Attenuates Diethylnitrosamine Induction of Hepatic Carcinogenesis Through Antioxidant Signaling

Thymoquinone: Potential cure for inflammatory disorders and cancer

Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

The rise (and fall?) of parental vaccine hesitancy

Hepatocellular carcinoma

Long-term effectiveness of population-wide multifaceted interventions for hepatocellular carcinoma in Taiwan

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals

Vaccine adjuvants – understanding molecular mechanisms to improve vaccines

Immunological responses following administration of a genotype 1a/1b/2/3a quadrivalent HCV VLP vaccine

Registers of the Swedish total population and their use in medical research

Global burden of liver disease: 2023 update

Hepatitis C Virus: 30 Years after Its Discovery

Comparison of the immunogenicity of the human papillomavirus (HPV)-16/18 vaccine and the HPV-6/11/16/18 vaccine for oncogenic non-vaccine types HPV-31 and HPV-45 in healthy women aged 18–45 years

A Randomized, Observer-Blinded Immunogenicity Trial of Cervarix® and Gardasil® Human Papillomavirus Vaccines in 12-15 Year Old Girls

Hepatocellular carcinoma

Burden of Disease and Cost of Chronic Hepatitis C Virus Infection in Canada

Hepatocellular Carcinoma

COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates

Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers

A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1

Human Papillomavirus and Cervical Cancer

Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases

EASL Recommendations on Treatment of Hepatitis C 2018

Continued low uptake of treatment for hepatitis C virus infection in a large community‐based cohort of inner city residents

EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma

Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs

The 3rd Canadian Symposium on Hepatitis C Virus: Expanding Care in the Interferon-Free Era

Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa

Mortality among British Columbians testing for hepatitis C antibody

Hepatitis C cross-genotype immunity and implications for vaccine development

HCV co-infection in HIV positive population in British Columbia, Canada

Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada

Differing profiles of people diagnosed with acute and chronic hepatitis B virus infection in British Columbia, Canada

Methadone Use in Relation to Hepatitis C Virus Testing in British Columbia

Human Papillomavirus 16 (HPV 16) and HPV 18 Antibody Responses Measured by Pseudovirus Neutralization and Competitive Luminex Assays in a Two- versus Three-Dose HPV Vaccine Trial

Methadone use in relation to hepatitis C virus testing in British Columbia.

Health Care Costs Associated with Hepatitis C: A Longitudinal Cohort Study

Publicly Funded, Pegylated Interferon-Alpha Treatment in British Columbia: Disparities in Treatment Patterns for People with Hepatitis C